• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激素替代疗法与女性帕金森病风险:14项观察性研究的荟萃分析

Hormone replacement therapy and Parkinson's disease risk in women: a meta-analysis of 14 observational studies.

作者信息

Wang Peifu, Li Jilai, Qiu Shi, Wen Honfeng, Du Jichen

机构信息

Department of Neurology, Aerospace Center Hospital, Peking University Aerospace Clinical College, Beijing, People's Republic of China.

出版信息

Neuropsychiatr Dis Treat. 2014 Dec 31;11:59-66. doi: 10.2147/NDT.S69918. eCollection 2015.

DOI:10.2147/NDT.S69918
PMID:25657580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4317144/
Abstract

BACKGROUND AND PURPOSE

Published data on the relationship of hormone replacement therapy (HRT) with Parkinson's disease (PD) were inconclusive. Thus, a systematic meta-analysis of observational studies was performed to clarify this topic.

METHODS

The databases of PubMed and EMBASE were searched for case-control or cohort studies published up till June 2, 2014. Meta-analysis of the relative risks (RRs) with 95% confidence intervals (CIs) was estimated using random-effects models.

RESULTS

A final total of ten case-control and four cohort studies were included in our meta-analysis. The overall combined RR of PD for ever users versus never users of HRT was 1.00 (95% CI: 0.84-1.20). Limited to those subjects who only use estrogen, a similar trend was detected (RR: 0.95, 95% CI: 0.69-1.30). In the subgroup analysis by study design, no significant association was observed in case-control studies (RR: 0.79, 95% CI: 0.62-1.02), whereas a positive association was found in cohort studies (RR: 1.24, 95% CI: 1.10-1.40). In further analysis according to study quality, an inverse association was found in the low-quality group (RR: 0.58, 95% CI: 0.40-0.82), whereas a positive association was found in the high-quality group (RR: 1.16, 95% CI: 1.02-1.31).

CONCLUSION

In summary, our results of meta-analysis do not support a protective role of HRT in female PD development.

摘要

背景与目的

关于激素替代疗法(HRT)与帕金森病(PD)关系的已发表数据尚无定论。因此,进行了一项观察性研究的系统荟萃分析以阐明该主题。

方法

检索了PubMed和EMBASE数据库中截至2014年6月2日发表的病例对照或队列研究。使用随机效应模型估计相对风险(RRs)及其95%置信区间(CIs)的荟萃分析。

结果

我们的荟萃分析最终共纳入了10项病例对照研究和4项队列研究。曾经使用过HRT的女性与从未使用过HRT的女性相比,患PD的总体合并RR为1.00(95%CI:0.84 - 1.20)。仅限于仅使用雌激素的受试者,也发现了类似趋势(RR:0.95,95%CI:0.69 - 1.30)。在按研究设计进行的亚组分析中,病例对照研究未观察到显著关联(RR:0.79,95%CI:0.62 - 1.02),而队列研究中发现了正相关(RR:1.24,95%CI:1.10 - 1.40)。根据研究质量进行的进一步分析中,低质量组发现了负相关(RR:0.58,95%CI:0.40 - 0.82),而高质量组发现了正相关(RR:1.16,95%CI:1.02 - 1.31)。

结论

总之,我们的荟萃分析结果不支持HRT在女性PD发生发展中具有保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73aa/4317144/652ed5e2beab/ndt-11-059Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73aa/4317144/ee5a3500437b/ndt-11-059Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73aa/4317144/e612b820ede3/ndt-11-059Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73aa/4317144/652ed5e2beab/ndt-11-059Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73aa/4317144/ee5a3500437b/ndt-11-059Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73aa/4317144/e612b820ede3/ndt-11-059Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73aa/4317144/652ed5e2beab/ndt-11-059Fig3.jpg

相似文献

1
Hormone replacement therapy and Parkinson's disease risk in women: a meta-analysis of 14 observational studies.激素替代疗法与女性帕金森病风险:14项观察性研究的荟萃分析
Neuropsychiatr Dis Treat. 2014 Dec 31;11:59-66. doi: 10.2147/NDT.S69918. eCollection 2015.
2
Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.生殖因素、绝经激素治疗与原发性肝癌风险:观察性研究的系统评价和剂量-反应荟萃分析。
Hum Reprod Update. 2016 Dec;23(1):126-138. doi: 10.1093/humupd/dmw037. Epub 2016 Sep 21.
3
Postmenopausal hormone replacement therapy: scientific review.绝经后激素替代疗法:科学综述。
JAMA. 2002 Aug 21;288(7):872-81. doi: 10.1001/jama.288.7.872.
4
Reproductive factors and risk of Parkinson's disease in women: A meta-analysis of observational studies.女性生殖因素与帕金森病风险:观察性研究的荟萃分析。
Behav Brain Res. 2017 Sep 29;335:103-110. doi: 10.1016/j.bbr.2017.07.025. Epub 2017 Jul 22.
5
The association between different hormone replacement therapy use and the incidence of lung cancer: a systematic review and meta-analysis.不同激素替代疗法的使用与肺癌发病率之间的关联:一项系统评价和荟萃分析。
J Thorac Dis. 2022 Feb;14(2):381-395. doi: 10.21037/jtd-22-48.
6
Association between coffee drinking and endometrial cancer risk: A meta-analysis.咖啡饮用与子宫内膜癌风险的关联:一项荟萃分析。
J Obstet Gynaecol Res. 2022 Mar;48(3):774-795. doi: 10.1111/jog.15139. Epub 2022 Jan 19.
7
Inflammatory bowel disease and risk of Parkinson's disease: evidence from a meta-analysis of 14 studies involving more than 13.4 million individuals.炎症性肠病与帕金森病风险:来自一项对14项研究的荟萃分析的证据,这些研究涉及超过1340万人。
Front Med (Lausanne). 2023 Apr 20;10:1137366. doi: 10.3389/fmed.2023.1137366. eCollection 2023.
8
Exogenous and endogenous hormones in relation to glioma in women: a meta-analysis of 11 case-control studies.外源和内源性激素与女性脑胶质瘤的关系:11 项病例对照研究的荟萃分析。
PLoS One. 2013 Jul 16;8(7):e68695. doi: 10.1371/journal.pone.0068695. Print 2013.
9
Hormone replacement therapy and lung cancer risk in women: a meta-analysis of cohort studies: Hormone replacement therapy and lung cancer risk.激素替代疗法与女性肺癌风险:队列研究的荟萃分析:激素替代疗法与肺癌风险
Medicine (Baltimore). 2019 Dec;98(51):e17532. doi: 10.1097/MD.0000000000017532.
10
Association between Statin Use and Risk of Parkinson's Disease: Evidence from 18 Observational Studies Comprising 3.7 Million Individuals.他汀类药物使用与帕金森病风险之间的关联:来自18项包含370万个体的观察性研究的证据。
J Pers Med. 2022 May 19;12(5):825. doi: 10.3390/jpm12050825.

引用本文的文献

1
Review of mendelian randomization studies on age at natural menopause.绝经年龄的孟德尔随机化研究综述。
Front Endocrinol (Lausanne). 2023 Sep 11;14:1234324. doi: 10.3389/fendo.2023.1234324. eCollection 2023.
2
Association of women-specific health factors in the severity of Parkinson's disease.帕金森病严重程度与女性特定健康因素的关联。
NPJ Parkinsons Dis. 2023 Jun 5;9(1):86. doi: 10.1038/s41531-023-00524-x.
3
A homozygous -associated juvenile Parkinson's disease with pregnancy in China.中国一例与纯合子相关的青少年帕金森病合并妊娠病例

本文引用的文献

1
Reproductive factors and Parkinson's disease risk in Danish women.丹麦女性的生殖因素与帕金森病风险
Eur J Neurol. 2014 Sep;21(9):1168-77, e68. doi: 10.1111/ene.12450. Epub 2014 Apr 22.
2
Female reproductive factors, menopausal hormone use, and Parkinson's disease.女性生殖因素、绝经激素使用与帕金森病
Mov Disord. 2014 Jun;29(7):889-96. doi: 10.1002/mds.25771. Epub 2013 Dec 18.
3
Exposure to estrogen and women's risk for Parkinson's disease: a prospective cohort study in Denmark.雌激素暴露与女性帕金森病风险:丹麦一项前瞻性队列研究。
Front Neurol. 2023 Feb 20;14:1103164. doi: 10.3389/fneur.2023.1103164. eCollection 2023.
4
State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson's disease: What meta-analysis studies cannot tell us.更年期与激素替代疗法与帕金森病关联的临床研究现状综述:荟萃分析研究无法告诉我们的内容。
Front Aging Neurosci. 2022 Oct 20;14:971007. doi: 10.3389/fnagi.2022.971007. eCollection 2022.
5
Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease.早发性帕金森病的年龄界定:国际帕金森病和运动障碍协会早发性帕金森病特别工作组的建议
Mov Disord Clin Pract. 2022 Sep 10;9(7):869-878. doi: 10.1002/mdc3.13523. eCollection 2022 Oct.
6
Sex Differences in Dopaminergic Vulnerability to Environmental Toxicants - Implications for Parkinson's Disease.环境毒物致多巴胺能神经元易损性的性别差异-对帕金森病的启示。
Curr Environ Health Rep. 2022 Dec;9(4):563-573. doi: 10.1007/s40572-022-00380-6. Epub 2022 Oct 6.
7
From Menopause to Neurodegeneration-Molecular Basis and Potential Therapy.从更年期到神经退行性变-分子基础与潜在治疗策略。
Int J Mol Sci. 2021 Aug 11;22(16):8654. doi: 10.3390/ijms22168654.
8
Menopausal hormone therapy and women's health: An umbrella review.绝经激素治疗与女性健康:伞式综述。
PLoS Med. 2021 Aug 2;18(8):e1003731. doi: 10.1371/journal.pmed.1003731. eCollection 2021 Aug.
9
Effects of the Menstrual Cycle on Neurological Disorders.月经周期对神经紊乱的影响。
Curr Neurol Neurosci Rep. 2021 May 10;21(7):34. doi: 10.1007/s11910-021-01115-0.
10
Non-Genetic Risk Factors for Parkinson's Disease: An Overview of 46 Systematic Reviews.帕金森病的非遗传风险因素:46 项系统评价综述。
J Parkinsons Dis. 2021;11(3):919-935. doi: 10.3233/JPD-202521.
Parkinsonism Relat Disord. 2013 Apr;19(4):457-60. doi: 10.1016/j.parkreldis.2013.01.008. Epub 2013 Feb 9.
4
Parkinson's disease: evidence for environmental risk factors.帕金森病:环境风险因素的证据。
Mov Disord. 2013 Jan;28(1):8-13. doi: 10.1002/mds.25150. Epub 2012 Oct 24.
5
Meta-analysis of early nonmotor features and risk factors for Parkinson disease.帕金森病早期非运动特征及危险因素的荟萃分析。
Ann Neurol. 2012 Dec;72(6):893-901. doi: 10.1002/ana.23687. Epub 2012 Oct 15.
6
Hormone replacement therapy and risk for neurodegenerative diseases.激素替代疗法与神经退行性疾病风险
Int J Alzheimers Dis. 2012;2012:258454. doi: 10.1155/2012/258454. Epub 2012 Apr 4.
7
Reproductive factors and Parkinson's disease: a multicenter case-control study.生殖因素与帕金森病:一项多中心病例对照研究。
Mov Disord. 2011 Dec;26(14):2563-6. doi: 10.1002/mds.23951. Epub 2011 Sep 28.
8
A randomized pilot trial of estrogen replacement therapy in post-menopausal women with Parkinson's disease.一项雌激素替代疗法治疗绝经后帕金森病女性的随机试验。
Parkinsonism Relat Disord. 2011 Dec;17(10):757-60. doi: 10.1016/j.parkreldis.2011.07.007. Epub 2011 Aug 6.
9
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.纽卡斯尔-渥太华量表在荟萃分析中评估非随机研究质量的批判性评价。
Eur J Epidemiol. 2010 Sep;25(9):603-5. doi: 10.1007/s10654-010-9491-z. Epub 2010 Jul 22.
10
Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease.生殖因素、外源性雌激素的使用与帕金森病风险
Mov Disord. 2009 Jul 15;24(9):1359-65. doi: 10.1002/mds.22619.